Exploring alternatives to plasmid DNA for safer, higher quality gene therapy
David McCall, Senior Editor, BioInsights, speaks with Nafiseh Nafissi, Chief Technology Officer, Mediphage Bioceuticals, about the applications and advantages of ministring DNA, including as the basis for a novel gene therapy modality.
Authors
- Nafiseh Nafissi (ORCID: https://orcid.org/0000-0002-6405-6172)
Institutions
- Office of the Chief Medical Examiner (CA)
Publication Details
- Journal
- Nucleic Acid Insights
- Published
- 2024-12-20
- DOI
- https://doi.org/10.18609/nai.2024.044
- Primary Topic
- RNA Interference and Gene Delivery
- Type
- article
- Field-Weighted Citation Impact
- 0.00